Market revenue in 2023 | USD 457.7 million |
Market revenue in 2030 | USD 665.9 million |
Growth rate | 5.5% (CAGR from 2023 to 2030) |
Largest segment | 2-way foley catheters |
Fastest growing segment | 3-way Foley Catheters |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | 2-way Foley Catheters, 3-way Foley Catheters, 4-way Foley Catheters |
Key market players worldwide | Sterimed Group, Angiplast, Cardinal Health Inc, Advin Health Care, Teleflex Inc, Medtronic PLC, ConvaTec Group PLC, B. Braun, BD, Hollister, Coloplast A/S ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to foley catheter market will help companies and investors design strategic landscapes.
2-way foley catheters was the largest segment with a revenue share of 52.2% in 2023. Horizon Databook has segmented the U.S. foley catheter market based on 2-way foley catheters, 3-way foley catheters, 4-way foley catheters covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing demand for the treatment of urinary diseases is the primary factor driving market expansion in the country. The U.S. Foley catheter market is primarily driven by the rising prevalence of urinary diseases and an increasing geriatric population experiencing bladder problems.
According to the Urology Care Foundation, in the U.S., 40% of women and 30% of men suffer from Overactive Bladder (OAB). As a result, the growing prevalence of urologic conditions is expected to drive the U.S. market. Advancements in medical technologies and treatment options have improved the management of OAB.
It includes the development, advancement, and launch of Foley catheters. For instance, In November 2021, , committed to advancing a superior option to the indwelling catheter, announced obtaining regulatory approval from the U.S. FDA for the commercialization of the FLUME catheter within the U.S.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. foley catheter market , including forecasts for subscribers. This country databook contains high-level insights into U.S. foley catheter market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account